Percutaneous transhepatic vascular embolization for a mesenteric arteriovenous malformation leading to decreased portal pressure in a patient with alcoholic liver cirrhosis: A case report [PDF]
Radiology Case ReportsArteriovenous malformations in the abdominal region are rare, and they are known to occasionally cause portal hypertension. A 66-year-old man with a chief complaint of fatigue and blood tests showing hepatic dysfunction was seen for a more detailed ...
Ken Shigeyama +8 more
doaj +2 more sources
Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure. [PDF]
Hepatology, 2019 Da BL +7 more
europepmc +5 more sources
Technique innovation of endoscopic ultrasound portal pressure gradient measurement using standard manometer set for portal hypertension assessment. [PDF]
Clin Case Rep, 2022 Lesmana CRA.
europepmc +3 more sources
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls [PDF]
Clinical and Molecular Hepatology, 2022 Transjugular intrahepatic portosystemic shunt (TIPS) is an effective interventional procedure to relieve portal hypertension, which is a main mechanism for the development of complications of liver cirrhosis (LC), such as variceal hemorrhage, ascites ...
Hae Lim Lee, Sung Won Lee
doaj +1 more source
Predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis [PDF]
PeerJ, 2023 Objective This study aimed to explore the predictive value of liver and spleen stiffness measurement based on two-dimensional shear wave elastography for the portal vein pressure in patients with compensatory viral cirrhosis. Methods From January 2017 to
Peng Wang, Xinhong Hu, Feng Xie
doaj +2 more sources
A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP). [PDF]
Trials, 2020 Gifford FJ +7 more
europepmc +3 more sources
Portosystemic shunt in the treatment of portal hypertension [PDF]
Vojnosanitetski Pregled, 2010 nema
Mirković Darko +2 more
doaj +1 more source
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure. [PDF]
PLoS ONE, 2013 OBJECTIVE: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol.
Mercedes Reboredo +13 more
doaj +1 more source
Managing liver cirrhotic complications: Overview of esophageal and gastric varices [PDF]
Clinical and Molecular Hepatology, 2020 Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality.
Cosmas Rinaldi Adithya Lesmana +2 more
doaj +1 more source
Amiloride reduces portal hypertension in rat liver cirrhosis [PDF]
, 2010 Objective This study aimed to investigate the effect of amiloride on portal hypertension. Amiloride is known to inhibit Na(+)/H(+) exchangers on activated hepatic stellate cells.
Beitinger, Frigga +6 more
core +1 more source